Terms: = Lymphoma AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2 AND Treatment
13 results:
1. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract] [Full Text] [Related]
2. Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
Chen Z; Huang H; Hong H; Huang H; Weng H; Yu L; Xiao J; Wang Z; Fang X; Yao Y; Yue JX; Lin T
Genome Med; 2024 Apr; 16(1):48. PubMed ID: 38566223
[TBL] [Abstract] [Full Text] [Related]
3. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
Sato S; Ishii M; Tachibana K; Furukawa Y; Toyota T; Kinoshita S; Azusawa Y; Ando J; Ando M
Exp Hematol; 2024 Feb; 130():104132. PubMed ID: 38029851
[TBL] [Abstract] [Full Text] [Related]
4. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.
Salmerón-Villalobos J; Castrejón-de-Anta N; Guerra-García P; Ramis-Zaldivar JE; López-Guerra M; Mato S; Colomer D; Diaz-Crespo F; Menarguez J; Garrido-Pontnou M; Andrés M; García-Fernández E; Llavador M; Frigola G; García N; González-Farré B; Martín-Guerrero I; Garrido-Colino C; Astigarraga I; Fernández A; Verdú-Amorós J; González-Muñíz S; González B; Celis V; Campo E; Balagué O; Salaverria I
Blood; 2023 Aug; 142(5):434-445. PubMed ID: 37053555
[TBL] [Abstract] [Full Text] [Related]
5. Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of ddx3x-TP53.
Gao F; Hu K; Zheng P; Shi H; Ke X
Cancer Med; 2023 May; 12(9):10267-10279. PubMed ID: 36971051
[TBL] [Abstract] [Full Text] [Related]
6. The X-Linked Helicase ddx3x Is Required for Lymphoid Differentiation and MYC-Driven lymphomagenesis.
Lacroix M; Beauchemin H; Fraszczak J; Ross J; Shooshtarizadeh P; Chen R; Möröy T
Cancer Res; 2022 Sep; 82(17):3172-3186. PubMed ID: 35815807
[TBL] [Abstract] [Full Text] [Related]
7. Failure of tofacitinib to achieve an objective response in a
Wong J; Wall M; Corboy GP; Taubenheim N; Gregory GP; Opat S; Shortt J
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843425
[TBL] [Abstract] [Full Text] [Related]
8. CD56-positive diffuse large B-cell lymphoma/leukemia with
Liu Y; Shen J; Awal Issah M; Liu T; Zhou H; Fu H
J Int Med Res; 2020 May; 48(5):300060520918087. PubMed ID: 32363958
[TBL] [Abstract] [Full Text] [Related]
9. Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting ddx3.
Fu R; Yang P; Li Z; Liu W; Amin S; Li Z
Cell Death Dis; 2019 Aug; 10(8):593. PubMed ID: 31391454
[TBL] [Abstract] [Full Text] [Related]
10. Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With "Hodgkin/Reed-Sternberg-like" Cells of NK Phenotype.
Chen Z; Liu W; Zhang W; Ye Y; Guan P; Gao L; Zhao S
Am J Surg Pathol; 2019 Dec; 43(12):1611-1621. PubMed ID: 31305266
[TBL] [Abstract] [Full Text] [Related]
11. Concise Review: Cheating Death for a Better Transplant.
Afreen S; Weiss JM; Strahm B; Erlacher M
Stem Cells; 2018 Nov; 36(11):1646-1654. PubMed ID: 30156339
[TBL] [Abstract] [Full Text] [Related]
12. Frequent Mutations in Natural Killer/T Cell lymphoma.
Zhang Y; Li C; Xue W; Zhang M; Li Z
Cell Physiol Biochem; 2018; 49(1):1-16. PubMed ID: 30134235
[TBL] [Abstract] [Full Text] [Related]
13. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
[TBL] [Abstract] [Full Text] [Related]